# Feasibility and Acceptability of a Multilayered COVID-19 Mitigation Intervention for Adults With Cancer

**Authors:** Michael Hoerger, Nicole Pyke, Danielle E. Zimmerman, Devabhaktuni Srikrishna, Nicole Garg, Brooke Mikles, Joseph Eastman, Caroline J. Hall, Rebecca G. Peter, James I. Gerhart

PMC · DOI: 10.1001/jamanetworkopen.2025.60547 · JAMA Network Open · 2026-02-24

## TL;DR

This study tested a comprehensive toolkit to reduce COVID-19 risks for cancer patients and found it feasible and acceptable.

## Contribution

The study introduces a multilayered mitigation toolkit tailored for cancer patients during the pandemic.

## Key findings

- The toolkit was found to be feasible to implement in clinical settings.
- Patients reported high acceptability of the mitigation strategies.
- The intervention had manageable costs for healthcare providers.

## Abstract

This quality improvement study evaluated the feasibility, acceptability, and cost of a multicomponent, multilayered COVID-19 mitigation toolkit for adults with cancer.

## Linked entities

- **Diseases:** cancer (MONDO:0004992), COVID-19 (MONDO:0100096)

## Full-text entities

- **Diseases:** respiratory infections (MESH:D012141), Cancer (MESH:D009369), long COVID (MESH:D000094024), deaths (MESH:D003643), COVID (MESH:D000086382), Infections (MESH:D007239)
- **Species:** Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Respiratory syncytial virus (no rank) [taxon 12814], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12933275/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12933275/full.md

---
Source: https://tomesphere.com/paper/PMC12933275